Conditions: Type 2 Diabetes Mellitus (T2DM)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 57
Healthy volunteers: no

Brief summary:
A clinical study to determine the safety, efficacy and the way sitagliptin works in patients with Type 2 Diabetes Mellitus who have inadequate glycemic (blood sugar) control.

Detailed description:

Arms:
arm 1: Participants randomized to this arm will be administered sitagliptin 100mg daily, for six weeks. arm 2: Participants randomized to this arm will be administered matching placebo, daily for six weeks.

Interventions: intervention 1: Comparator: sitagliptin phosphate intervention 2: Comparator: placebo (unspecified)
Intervention descriptions: intervention 1: Sitagliptin tablet 100 mg, administered once daily before the morning meal. intervention 2: Matching placebo tablet, administered once daily before the morning meal.

Protocol document: